Skip to content

Clinical trials

Phase 2 Leiomyoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyoma Phase: Phase 2 Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20041
20065
20082
20092
20101
20112
20123
20131
20142
20154
20161
20182
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Repros Therapeutics Inc.10
Abbott3
Bayer2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Johns Hopkins University2
Takeda2
AbbVie1
AbbVie (prior sponsor, Abbott)1
Assistance Publique - Hôpitaux de Paris1
BioPro Medical Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyoma35
Menorrhagia3
Myofibroma3
Agnosia2
Fibroma2
Uterine Neoplasms2
Ileus1
Uterine Hemorrhage1

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.